Diabetes Reversed in Mice with Genetically Edited Stem Cells Derived from Patients
NCER Comments:
Diabetes Mellitus (DM) affects more than 100 million adults in the US; that’s just under 10% of the population. Diabetes is associated with a 2x increase of death due to cardiovascular disease; and on average, patients with diabetes lose 6 years of their lifespan compared to those who do not. Additionally, DM is the leading cause of kidney failure, retinopathy and neuropathic pain. Can CRISPR-cas 9 be utilized to ethically cure …
Alberta woman 1st adult in Canada to be ‘cured’ of sickle cell anemia through stem cell transplant
A stem cell first for Canada! An Alberta woman is the first adult in Canada to be cured of sickle cell anemia with the help of a stem cell transplant from her sister. This is a great example of the Ethical use of stem cells !
· CBC News ·
Revée Agyepong of Edmonton underwent the procedure at Calgary cancer centre with donor cells from sister
An Alberta woman …
Parenting of the future: Many embryos, each with DNA profile
NEW YORK (AP) — So you want to have a baby.
Would you like
After 14 years, California’s stem cell agency finally gets a royalty cheque
BioEdge by Michael Cook | 4 Mar 2018
Fourteen years after Californians voted an overwhelming Yes! to stem cell research, including human embryonic stem cells, and created the California Institute for Regenerative Medicine (CIRM), the agency has received its first royalty cheque. The amount? US$190,345.87.
Not even the staff of the controversial CIRM were inclined to boast about the return on investment for Californian tax-payers. Proposition 71, which voters approved in 2004, authorised a $3 …
Welcome to the CRISPR Zoo!
Nature Sara Reardon 3/09/2016
Timothy Doran’s 11-year-old daughter is allergic to eggs. And like about 2% of children worldwide who share the condition, she is unable to receive many routine vaccinations because they are produced using chicken eggs.
Doran, a molecular biologist at the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Geelong, Australia, thinks that he could solve this problem using the powerful gene-editing tool CRISPR–Cas9. Most egg allergies are caused by one of …
CRISPR: The New Tool in the Gene Editing Revolution Explained
ABC Science By Bernie Hobbs Updated 11 Apr 2016, 11:03pm
A powerful new gene-editing technology called CRISPR has enormous potential to treat human diseases but the ability to tinker with genes can also be controversial. Here we explain what CRISPR is and how it works.
Since gene technology first emerged over 40 years ago we’ve seen a wealth of genetic advances — not least of all the decoding of the human genome in 2001.
Key
Supercharging Stem Cells to Create New Therapies
As seen in Science Daily:July 3, 2015
Source:University of Adelaide
Summary:
A new method for culturing stem cells has been developed, which sees the highly therapeutic cells grow faster and stronger. Stem cell therapy is showing promising signs for transplant patients, and the IL-17 treated stem cells should be even more effective at preventing and treating inflammation in transplant recipients — particularly controlling rejection in transplant patients.
Researchers at the University of Adelaide have discovered …
A guide to CRISPR, the human gene-editing tool that has scientists excited — and terrified
We are now one step closer to designer babies. Using a technique called CRISPR, geneticists in China recently modified the DNA of nonviable human embryos and published the results in the journal Protein & Cell.
Editing the genetic material of human embryos was a first — and the April 18 publication of the results set off a cascade of awe and controversy.
“While these embryos will not be growing up into genetically modified people,” …
NHS to give volunteers ‘synthetic blood’ made in laboratory within two years
as seen in THE INDEPENDENT
- SUNDAY 28 JUNE 2015
The first attempt at giving human volunteers “synthetic blood” made in a laboratory for the first time will take place within the next two years, the NHS has announced.
…
Gene, stem cell therapies may have far-reaching implications for coronary artery grafts
As seen in Science Daily – June 9, 2015
Source:Creighton University
Summary:Researchers are exploring the potential for gene and stem cell therapy in coronary artery bypass grafts to prevent re-occlusion in the grafted vein. Based on animal studies, the team is seeing a marked improvement in preventing re-occlusion, with no side effects
A Creighton University researcher has received a National Institutes of Health grant to study the effects of gene and stem cell therapy in …
Jun